Stock Research for AEZS

AEZS
Current Price

$2.0800


Latest Update: 2018-01-16 16:00:00

High
$ 2.0800
Low
$ 2.0700
Close
$ 2.0700
Volume
3300
 
  

Featured Broker: TradeStation

Get the due diligence for another stock.

 

AEZS Stock Chart & Research Data

The AEZS chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the AEZS chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


AEZS Due diligence Resources & Stock Charts

The AEZS stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View AEZS Detailed Price Forecast - CNN Money CNN View AEZS Detailed Summary - Google Finance
Yahoo View AEZS Detailed Summary - Yahoo! Finance Zacks View AEZS Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View AEZS Trends & Analysis - Trade-Ideas Barrons View AEZS Major Holders - Barrons
NASDAQ View AEZS Call Transcripts - NASDAQ Seeking View AEZS Breaking News & Analysis - Seeking Alpha
Spotlight View AEZS Annual Report - CompanySpotlight.com OTC Report View AEZS OTC Short Report - OTCShortReport.com
TradeKing View AEZS Fundamentals - TradeKing Charts View AEZS SEC Filings - Bar Chart
WSJ View Historical Prices for AEZS - The WSJ Morningstar View Performance/Total Return for AEZS - Morningstar
MarketWatch View the Analyst Estimates for AEZS - MarketWatch CNBC View the Earnings History for AEZS - CNBC
StockMarketWatch View the AEZS Earnings - StockMarketWatch MacroAxis View AEZS Buy or Sell Recommendations - MacroAxis
Bullish View the AEZS Bullish Patterns - American Bulls Short Pains View AEZS Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View AEZS Stock Mentions - StockTwits PennyStocks View AEZS Stock Mentions - PennyStockTweets
Twitter View AEZS Stock Mentions - Twitter Invest Hub View AEZS Investment Forum News - Investor Hub
Yahoo View AEZS Stock Mentions - Yahoo! Message Board Seeking Alpha View AEZS Stock Mentions - Seeking Alpha




Financial & Transaction Holdings

SECform4 View Insider Transactions for AEZS - SECform4.com Insider Cow View Insider Transactions for AEZS - Insider Cow
CNBC View AEZS Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for AEZS - OTC Markets
Yahoo View Insider Transactions for AEZS - Yahoo! Finance NASDAQ View Institutional Holdings for AEZS - NASDAQ


Stock Charts

FinViz View AEZS Stock Insight & Charts - FinViz.com StockCharts View AEZS Investment Charts - StockCharts.com
BarChart View AEZS Stock Overview & Charts - BarChart Trading View View AEZS User Generated Charts - Trading View


Latest Financial News for AEZS

Aeterna Zentaris Provides Update on Litigation against David Dodd and Philip Theodore
Posted on Friday December 22, 2017

CHARLESTON, S.C., Dec. 22, 2017-- Aeterna Zentaris Inc., a specialty biopharmaceutical company engaged in developing and commercializing pharmaceutical therapies, announced today that it is in receipt ...


Aeterna Zentaris jumps on FDA approval, Honda bets on solid-state battery, Rolling Stone is sold
Posted on Thursday December 21, 2017

Aeterna Zentaris, Honda, Rolling Stone and Didi Chuxing are the companies to watch.


Stocks push slightly higher, President Trump prepares to sign tax bill into law
Posted on Thursday December 21, 2017

Yahoo Finance's LIVE market coverage and analysis of what you need to watch in the stock market begins each day at 9:25 a.m. ET.


Aeterna Zentaris' stock soars toward 8-month high after Macrilen granted marketing approval
Posted on Thursday December 21, 2017

Shares of AEterna Zentaris Inc. rocketed 66% in premarket trade, putting them on track to open at an eight-month high, after the biopharmaceutical company said Macrilen, used in the diagnosis of patients ...


AEterna Zentaris Inc.
MarketWatch - Dec 21, 2009
Your Daily Pharma Scoop: AEterna Zentaris Gets FDA Nod, Valeant Finalizes Sprout Sale, Roche Gets EC Approval. Your Daily Pharma Scoop: AEterna Zentaris Gets FDA Nod, Valeant Finalizes Sprout Sale, Roche Gets EC Approval.

Our Readers Just Scored Big On AEterna Zentaris Inc. (USA) (NASDAQ:AEZS)
Insider Financial - Dec 22, 2017
Back in August, we published this piece on AEterna Zentaris Inc. (USA) (NASDAQ:AEZS). At the time, the company had just collapsed subsequent to a substantial run and we said that markets were missing a strong potential upside catalyst in their ...
AEterna Zentaris Inc. (USA) (AEZS) Investors Celebrate FDA Approval; Shares ... - Smarter Analyst
AEterna Zentaris (AEZS) Stock: Flying On FDA Approval - CNA Finance (press release)

Maxim Hikes Price Targets on 2 Biotech Stocks: AEterna Zentaris Inc. (USA ...
Smarter Analyst - Jul 19, 2017
Many investors hope to win big on biotech stocks as shares can skyrocket when there is good news. Maxim analysts explain why there are plenty of promising developments in store for AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) and Vertex Pharmaceuticals ...
AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) Explodes After Macrilen NDA Milestone - StockNewsUnion

AEterna Zentaris Inc. (USA) (AEZS) CEO's Departure Raises Questions
Smarter Analyst - Jul 24, 2017
AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) shares are tumbling nearly 7% in Monday's trading session, following the news that CEO David Dodd is stepping down and will be succeed by Michael Ward.

Enter a stock symbol to view the stock details.